A phase II trial of a multi‐agent oral antiangiogenic (metronomic) regimen in children with recurrent or progressive cancer-Reference-Cited by-同舟云学术

A phase II trial of a multi‐agent oral antiangiogenic (metronomic) regimen in children with recurrent or progressive cancer

Published:2013-10-04 Issue:4 Volume:61 Page:636-642
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatr Blood Cancer

Author:

Robison Nathan J.¹²,Campigotto Federico³,Chi Susan N.¹²,Manley Peter E.¹²,Turner Christopher D.¹²,Zimmerman Mary Ann¹²,Chordas Christine A.¹²,Werger Annette M.¹²,Allen Jeffrey C.⁴,Goldman Stewart⁵,Rubin Joshua B.⁶,Isakoff Michael S.⁷,Pan Wilbur J.⁸,Khatib Ziad A.⁹,Comito Melanie A.¹⁰,Bendel Anne E.¹¹,Pietrantonio Jay B.¹²,Kondrat Laura¹²,Hubbs Shannon M.¹²,Neuberg Donna S.³,Kieran Mark W.¹²

Affiliation:

1. Department of Pediatric OncologyDana‐Farber Cancer InstituteBostonMassachusetts

2. Division of Pediatric Hematology–OncologyDepartment of PediatricsBoston Children's HospitalBostonMassachusetts

3. Department of Biostatistics and Computational BiologyDana‐Farber Cancer InstituteBostonMassachusetts

4. NYU Langone Medical CenterNew YorkNew York

5. Lurie Children's HospitalNorthwestern University Feinberg School of Medicine ChicagoChicagoIllinois

6. Department of PediatricsSt. Louis Children's HospitalWashington University School of MedicineSt. LouisMissouri

7. Division of Hematology/OncologyConnecticut Children's Medical CenterHartfordConnecticut

8. UMDNJ‐Robert Wood Johnson Medical SchoolNew BrunswickNew Jersey

9. Department of PediatricsMiami Children's HospitalFlorida International UniversityMiamiFlorida

10. Penn State Hershey Children's HospitalHersheyPennsylvania

11. Children's Hospital and Clinics of MinnesotaMinneapolis/Saint PaulMinnesota

Funder

Alex's Lemonade Stand Foundation for Childhood Cancer

Stop & Shop Pediatric Brain Tumor Research Fund

Pediatric Brain Tumor Research and Clinical Fund Support for data management was provided by Celgene Pharmaceutical Corporation

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology, and Child Health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pbc.24794

Reference31 articles.

1. Combinatorial drug therapy for cancer in the post-genomic era

2. Tumor Angiogenesis: Therapeutic Implications

3. How is blood vessel growth regulated in normal and neoplastic tissue? G.H.A. Clowes memorial Award lecture;Folkman J;Cancer Res,1986

4. Development of novel targeted therapies in the treatment of malignant glioma

5. Importance of dose intensity in neuro‐oncology clinical trials: Summary report of the Sixth Annual Meeting of the Blood–Brain Barrier Disruption Consortium;Doolittle ND;Neuro Oncol,2001

Cited by 120 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pediatric Neuroglial Tumors: A Review of Ependymoma and Dysembryoplastic Neuroepithelial Tumor;Pediatric Neurology;2024-07

2. Chemotherapy in pediatric low-grade gliomas (PLGG);Child's Nervous System;2024-05-31

3. Real-life experience with a “modified-MEMMAT” regimen for relapsed medulloblastoma;2024-05-29

4. Optimizing cancer therapy: a review of the multifaceted effects of metronomic chemotherapy;Frontiers in Cell and Developmental Biology;2024-05-15

5. Metronomic Chemotherapy for Pediatric Refractory Solid Tumors: A Retrospective Single-Center Study;Journal of Pediatric Hematology/Oncology;2024-04-29